Clinical Trial Update: Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating rivastigmine alone and in combination with memantine in moderately severe Alzheimer's disease patients who did not benefit from prior c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Memantine (memantine)
• Rivastigmine (Rivastigmine)

Snippet

Sponsor: Novartis | Conditions: Alzheimer's Disease | Phase 4 | Status: COMPLETED